X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse AANJANEYA LIFECARE with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. DATSONS LABS   TEVA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
TEVA PHARMA
Dec-13
DR. DATSONS LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1262,664-   
Low Rs312,314-   
Sales per share (Unadj.) Rs133.01,528.8-  
Earnings per share (Unadj.) Rs0.295.5-  
Cash flow per share (Unadj.) Rs6.6219.1-  
Dividends per share (Unadj.) Rs083.60-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs128.81,698.2-  
Shares outstanding (eoy) m31.66848.00-   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.6 36.1%   
Avg P/E ratio x516.126.1 1,980.4%  
P/CF ratio (eoy) x11.811.4 104.2%  
Price / Book Value ratio x0.61.5 41.5%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m2,4772,110,655 0.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m560-   
Avg. sales/employee Rs ThNM28,845.0-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,801.9-  
INCOME DATA
Net Sales Rs m4,2111,296,439 0.3%  
Other income Rs m790-   
Total revenues Rs m4,2891,296,439 0.3%   
Gross profit Rs m569355,031 0.2%  
Depreciation Rs m204104,792 0.2%   
Interest Rs m43025,464 1.7%   
Profit before tax Rs m13224,774 0.0%   
Minority Interest Rs m01,021 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-147,552 0.0%   
Tax Rs m6-2,744 -0.2%   
Profit after tax Rs m580,988 0.0%  
Gross profit margin %13.527.4 49.3%  
Effective tax rate %48.0-1.2 -3,934.1%   
Net profit margin %0.16.2 1.8%  
BALANCE SHEET DATA
Current assets Rs m6,852875,610 0.8%   
Current liabilities Rs m6,711763,606 0.9%   
Net working cap to sales %3.38.6 38.8%  
Current ratio x1.01.1 89.0%  
Inventory Days Days16191 177.1%  
Debtors Days Days31896 332.0%  
Net fixed assets Rs m3,673423,446 0.9%   
Share capital Rs m3173,191 9.9%   
"Free" reserves Rs m3,7610-   
Net worth Rs m4,0781,440,098 0.3%   
Long term debt Rs m1,671662,898 0.3%   
Total assets Rs m12,6332,962,780 0.4%  
Interest coverage x1.09.8 10.5%   
Debt to equity ratio x0.40.5 89.0%  
Sales to assets ratio x0.30.4 76.2%   
Return on assets %3.43.6 95.8%  
Return on equity %0.15.6 2.1%  
Return on capital %7.74.9 155.6%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Net fx Rs m3570-   
CASH FLOW
From Operations Rs m1,345206,585 0.7%  
From Investments Rs m-2,256-73,202 3.1%  
From Financial Activity Rs m-1,200-247,813 0.5%  
Net Cashflow Rs m-2,111-114,429 1.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 63.82 Rs / USD

Compare DR. DATSONS LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare DR. DATSONS LABS With: CIPLA  WYETH LTD  STERLING BIOTECH  ALEMBIC PHARMA  MERCK LTD  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views On News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS